| Bioactivity | HYL001 (compund 338) is a potent inhibitor of TGFβ receptor 1 (ALK5) that is approximately 9 times more potent than the structurally related compound Galunisertib (HY-13226) and is able to eliminate liver metastases established in mice[1]. |
| Target | TGFβ |
| CAS | 2426547-83-1 |
| Formula | C21H18N4O |
| Molar Mass | 342.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WO2020104648 |